Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14638
Full Text
Open PDFAbstract
Available in full text
Date
April 19, 2018
Authors
Publisher
Wiley